VivoSeq
Psychiatry

Opioid Use Disorders

3

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Opioid Use Disorders is an early-stage landscape with 3 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 13

Inhaled Cannabis

University of California, Davis

Intransal Opioid

University of Kentucky

Intranasal Opioid

University of Kentucky

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

1

clinical trials

Not yet recruiting1 · 100%

Clinical Trials

Trial Activity

Cannabis and Opioid Use Disorder, Study 2
Not yet recruiting·UUniversity of Kentucky·Phase 1·NCT07661446·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)